α-Galactosylceramide as a Therapeutic Agent for PulmonaryMycobacterium tuberculosisInfection
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
α-Galactosylceramide as a Therapeutic Agent for PulmonaryMycobacterium tuberculosisInfection
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Volume 182, Issue 6, Pages 841-847
Publisher
American Thoracic Society
Online
2010-05-28
DOI
10.1164/rccm.200912-1921oc
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of Invariant NKT Cells Ameliorates Experimental Ocular Autoimmunity by A Mechanism Involving Innate IFN- Production and Dampening of the Adaptive Th1 and Th17 Responses
- (2014) R. S. Grajewski et al. JOURNAL OF IMMUNOLOGY
- Rapid NKT Cell Responses Are Self-Terminating during the Course of Microbial Infection
- (2014) A. Chiba et al. JOURNAL OF IMMUNOLOGY
- Combination therapy ofin vitro-expanded natural killer T cells and α-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma
- (2009) Naoki Kunii et al. CANCER SCIENCE
- Incorporation of NKT Cell-Activating Glycolipids Enhances Immunogenicity and Vaccine Efficacy of Mycobacterium bovis Bacillus Calmette-Guerin
- (2009) M. M. Venkataswamy et al. JOURNAL OF IMMUNOLOGY
- A Phase I-II Study of -Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer
- (2009) S. Motohashi et al. JOURNAL OF IMMUNOLOGY
- Human NKT cells promote monocyte differentiation into suppressive myeloid antigen-presenting cells
- (2009) Subramanya Hegde et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Immunomodulation with Recombinant Interferon-γ1b in Pulmonary Tuberculosis
- (2009) Rod Dawson et al. PLoS One
- Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity
- (2009) C. Guillonneau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities
- (2009) L. Wu et al. TISSUE ANTIGENS
- Clinical applications of natural killer T cell–based immunotherapy for cancer
- (2008) Shinichiro Motohashi et al. CANCER SCIENCE
- Mechanism of NKT cell activation by intranasal coadministration of α-galactosylceramide, which can induce cross-protection against influenza viruses
- (2008) H Kamijuku et al. Mucosal Immunology
- α-Galactosylceramide enhances the protective and therapeutic effects of tumor cell based vaccines for ovarian tumors
- (2008) Youn Seok Choi et al. VACCINE
- Activation of Invariant NKT Cells Exacerbates Experimental Visceral Leishmaniasis
- (2008) Amanda C. Stanley et al. PLoS Pathogens
- Innate Invariant NKT Cells Recognize Mycobacterium tuberculosis–Infected Macrophages, Produce Interferon-γ, and Kill Intracellular Bacteria
- (2008) Isabel Sada-Ovalle et al. PLoS Pathogens
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started